新的机器学习技术进一步澄清了与无关的供体选择,以优化移植结果
Stephen R Spellman1, Rodney Sparapani2, Martin Maiers1
1Center for International Blood and Marrow Transplant Research, NMDP, Minneapolis, MN.
Blood advances
|October 5, 2024
概括
捐赠者的年龄和性别对异质造血细胞移植 (HCT) 的结果产生影响. 建议年轻的捐赠者 (18-30岁) 获得更好的整体存活率,而男性捐赠者可以改善无事件存活率.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 机器学习在医学中的应用
背景情况:
- 全基性造血细胞移植 (HCT) 的结果受到众多因素的影响.
- 确定最佳的捐赠者特征对于改善患者存活率和减少并发症至关重要.
- 之前的研究对捐赠者的影响产生了相互矛盾的结果.
研究的目的:
- 调查捐赠者特征对非相关捐赠HCT接受者的整体存活率 (OS) 和无事件存活率 (EFS) 的影响.
- 应用一种新的机器学习方法,即非参数失效时间贝叶斯增量回归树 (NFT BART),进行可靠的分析.
- 对于捐赠变量来定义具有临床意义的影响 (>1%的3年差异).
主要方法:
- 在10016名接受首次HLA-A,B,C,DRB1治疗的患者中,训练有素的NFT BART模型匹配了与无关的捐赠者HCT (2016-2019).
- 在1802名患者的独立队列上验证了模型.
- 对接受者,疾病和移植变量进行调整的模型.
主要成果:
- 与18岁的捐赠者相比,捐赠者的年龄 (≥31岁) 与总体存活率较低有关.
- 较年轻的捐赠者年龄 (≤32岁) 和男性捐赠者使用改善了无事件生存率.
- 捐赠细胞巨乳病毒状态,平价和HLA-DQB1/DPB1T细胞表皮质匹配显示出最小的影响.
结论:
- 建议选择最年轻的可用捐赠者 (18-30岁),以优化HCT的整体存活率.
- 如果有多个年轻的捐赠者可用,可以考虑男性捐赠者,以潜在地提高无事件生存率.
- NFT BART提供了一种强大的工具,用于剖析HCT中复杂的供体-受体相互作用.
相关概念视频
Kidney Transplant I: Introduction
2
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
2
Bone Marrow Sampling and Transplants
313
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
313
Tissue Transplantation
341
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
341
Kidney Transplant II: Surgical Procedure
2
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
2


